Fig. 3From: Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysisOdds of all-cause 30-day mortality after propensity score-overlap weighting for andexanet alfa versus 4F-PCC (referent). AA = andexanet alfa, CI = confidence interval, 4F-PCC = four-factor prothrombin complex concentrate, OR = odds ratioBack to article page